Workflow
Insider ownership
icon
Search documents
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy?
Yahoo Financeยท 2025-11-19 22:15
Biohaven Ltd. is a clinical-stage biopharmaceutical company specializing in the research and development of therapies for neurological and immunoscience conditions. With a focused pipeline and a strategy centered on scientific innovation, Biohaven aims to address significant gaps in current treatment paradigms.Biohaven serves healthcare providers and patients impacted by neurological and immune-related disorders, targeting unmet medical needs in these populations.The company operates as a biotechnology comp ...